Clinical Guidelines for Ibogaine-Assisted Detoxification

[Praxis.]

Today begins the second public consultation period for The Global Ibogaine Therapy Alliance's Clinical Guidelines for Ibogaine-Assisted Detoxification.

This consultation period will end on August 10th, and is the final opportunity for input into Version 1 of this document to be published in early September, 2015.

Please take the time this month to review this landmark document and help make it as accurate and effective as possible! Your input is very much appreciated.

The link above goes to the google doc, and I've also attached a .pdf for easy download.

 

[332211]

p49

to:
If anxiety persists, benzodiazepines may be administered. For non-dependent or benzo-naïve patients, .25 to .5 mg of alprazolam should be used. Doses of 5 to 10 mg of oral diazepam may be used for benzo-dependent patients. In some cases, use of alprazolam may provide more acute relief, even in benzo-dependent patients, but watch for peaks and valleys of withdrawals. Refer to previous notes about benzodiazepines (Ch. 4).


from:
If anxiety persists, benzodiazepines may be administered. Doses of 5 to 10 mg of oral diazepam may be used for benzo-dependent patients. For non-dependent or benzo-naïve patients, .25 to .5 mg of alprazolam should be used. In some cases, use of alprazolam may provide more acute relief, even in benzo-dependent patients, but watch for peaks and valleys of withdrawals. Refer to previous notes about benzodiazepines (Ch. 4).

why:
better structure

 

[Praxis.]

I believe any suggestions you have can be left on the google doc to ensure that they are seen.